Astrana Health (NASDAQ:ASTH) Sets New 52-Week Low – What’s Next?

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week low during mid-day trading on Friday . The company traded as low as $32.54 and last traded at $32.83, with a volume of 53825 shares changing hands. The stock had previously closed at $33.53.

Wall Street Analyst Weigh In

A number of analysts recently commented on ASTH shares. Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. TD Cowen initiated coverage on Astrana Health in a research note on Monday, October 14th. They set a “buy” rating and a $66.00 price objective on the stock. KeyCorp began coverage on Astrana Health in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. Robert W. Baird upped their price target on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, BTIG Research raised their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $65.17.

Astrana Health Stock Down 3.1 %

The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. The firm has a market cap of $1.83 billion, a P/E ratio of 25.00, a PEG ratio of 1.80 and a beta of 1.13. The company’s 50 day simple moving average is $45.01 and its 200-day simple moving average is $47.61.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million for the quarter, compared to the consensus estimate of $462.01 million. During the same period in the previous year, the business earned $0.47 earnings per share. Research analysts forecast that Astrana Health, Inc. will post 1.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of hedge funds and other institutional investors have recently bought and sold shares of ASTH. State Street Corp acquired a new position in Astrana Health during the 3rd quarter valued at about $91,966,000. Geode Capital Management LLC acquired a new position in shares of Astrana Health during the third quarter valued at about $58,995,000. FMR LLC purchased a new position in shares of Astrana Health in the 3rd quarter valued at approximately $48,413,000. SteelPeak Wealth LLC purchased a new stake in Astrana Health during the 3rd quarter worth approximately $39,398,000. Finally, Loomis Sayles & Co. L P purchased a new position in Astrana Health in the 3rd quarter worth $30,251,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.